India's Richest People 2026 edition · 1 director · Source: Hurun India
- #1,374 AM Gopalan & family ₹1,600 Cr
Zebx Pharmaceuticals Private Limited
Zebx Pharmaceuticals Private Limited - education & learing in Bangalore, Karnataka, India. Directors, charges & compliance details.
Active Private Limited Company education and learing
Revenue · FY 2025
₹2.08 Cr
▲ 492% YoY
Net profit · FY 2025
₹12.25 Lakh
Net margin 5.9%
EBITDA · FY 2025
₹14.65 Lakh
EBITDA margin 7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5.67 Lakh
Issued & subscribed
Open charges
₹4 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
About Zebx Pharmaceuticals Private Limited
Data last updated:
Zebx Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the education and training segment of the education and learning sector. It was incorporated on 12 December 2018 and has been in existence for over 8 years.
Its director AM Gopalan and family are #1,374 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U80904KA2018PTC119385.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5.67 Lakh. It is led by directors including Manojan Kannan Kandiyil (Managing Director) and Gopalan Sheeja.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.60 15th Main Road Rajmahal Vilas Extension (Rmv Extn), Bangalore, Karnataka, India – 560080.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.08 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹12.25 Lakh (net margin 5.9%) and EBITDA of ₹14.65 Lakh (EBITDA margin 7%). Revenue has grown at a compounded annual rate (CAGR) of 40% over five years.
As per MCA filings, the company has open charges of ₹4 Cr on record.
Company details
CIN U80904KA2018PTC119385
Registration Number 119385
Incorporation Date 12 December 2018
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Key People
Manojan Kannan Kandiyil Managing Director Gopalan Sheeja Director Gopalan Ambalathil Meethal Director Recognitions & Rankings of Zebx Pharmaceuticals
Contact details
Zebx Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka.
- Registered AddressNo.60 15th Main Road Rajmahal Vilas Extension (Rmv Extn), Bangalore, Karnataka, India – 560080
- IndustryEducation & Learing, Education, Education Itraining
Comprehensive company report
Zebx Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Zebx Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Zebx Pharmaceuticals Private Limited, buy the company report.
Financials of Zebx Pharmaceuticals Private Limited
FY 2025 filings availableZebx Pharmaceuticals Private Limited reported revenue of ₹2.08 Cr (up 492% YoY) for FY 2025.
Revenue · FY 2025
₹2.08 Cr ▲ 492%
Net profit · FY 2025
₹12.25 Lakh margin 5.9%
EBITDA · FY 2025
₹14.65 Lakh margin 7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 492%
5 years · compounded
▲ 40%
EBITDA CAGR growth
1 year
▲ 317%
3 years · compounded
▲ 99%
5 years · compounded
▲ 60%
Revenue has grown at a compounded annual rate (CAGR) of 40% over five years, including 492% growth in the latest year. EBITDA rose 317% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.25 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7% | ||||
| Net Profit Margin | 5.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zebx Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zebx Pharmaceuticals Private Limited
Zebx Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gopalan Sheeja | Director | 12 Dec 2018 | 7 Years 10 Months | Current |
| Manojan Kannan Kandiyil Also directs: Paragon Hospital Kerala Private Limited, Sree Gokulam Pharma Private Limited, Virtualshowkaze Ventures Private Limited and 1 more | Managing Director | 12 Dec 2018 | 7 Years 10 Months | Current |
| Gopalan Ambalathil Meethal Also directs: Sree Gokulam Seek Edu LLP, Gokulam KVH Baby Care Product LLP, Sree Gokulam Five Flours LLP and 5 more | Director | 25 Mar 2023 | 3 Years 6 Months | Current |
Peer comparison
Zebx Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Relic Biotechnology Private Limited | ₹2.09 Cr (FY 2025) | -8.0% | Pune, Maharashtra, India | |||
| Phenix Pharma Private Limited | ₹2.09 Cr (FY 2022) | -31.0% | Vadodara, Gujarat, India | |||
| Seven Hiills Softgel Private Limited | ₹2.08 Cr (FY 2021) | 20.0% | Hyderabad, Telangana, India | |||
| Zebx Pharmaceuticals Private Limitedthis company | ₹2.08 Cr (FY 2025) | ₹12.25 Lakh | 5.9% | 492.0% | Bangalore, Karnataka, India | |
| Nine Labs Private Limited | ₹2.08 Cr (FY 2025) | -34.0% | Hyderabad, Telangana, India | |||
| Macromed Pharmaceuticals Private Limited | ₹2.07 Cr (FY 2020) | -1.0% | Puducherry, India | |||
| Shona Pharmaceuticals Private Limited | ₹2.07 Cr (FY 2015) | 4098650.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Zebx Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Nov 2025 | 101186628 | Others | ₹4 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Zebx Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zebx Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Zebx Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Zebx Pharmaceuticals Private Limited has 6 board changes on record since 2018: 3 appointments and 3 cessations. The latest: Manojan Kannan Kandiyil ceased to be Director on 02 Feb 2025.
Charges
A charge with Others amounted to Rs. 400.00 Lakh with Charge ID 101186628 was registered on 17 Nov 2025.
AGM
Zebx Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Zebx Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Manojan Kannan Kandiyil ceased to be Director.
Ceased
Gopalan Ambalathil Meethal ceased to be Additional Director.
Appointed
Gopalan Ambalathil Meethal was appointed as Director.
Ceased
Sunil Kumar ceased to be Director.
Appointed
Gopalan Sheeja was appointed as Director.
Appointed
Manojan Kannan Kandiyil was appointed as Managing Director.
Incorporation
12 Dec 2018
Zebx Pharmaceuticals Private Limited was registered on 12 Dec 2018 with Roc Bangalore & aged 7 years 10 months as per MCA records.
Frequently asked questions
Zebx Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in education, within the education and learning industry. It was incorporated on 12 December 2018 (8+ years old) and is registered under CIN U80904KA2018PTC119385.
Zebx Pharmaceuticals has 3 current directors:
- Manojan Kannan Kandiyil - Managing Director
- Gopalan Sheeja - Director
- Gopalan Ambalathil Meethal - Director
The latest financial statements of Zebx Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Zebx Pharmaceuticals is U80904KA2018PTC119385. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zebx Pharmaceuticals was incorporated on 12 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Zebx Pharmaceuticals by revenue are Relic Biotechnology Private Limited, Phenix Pharma Private Limited, Seven Hiills Softgel Private Limited, Nine Labs Private Limited, Macromed Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Manojan Kannan Kandiyil ceased to be Director on 02 Feb 2025. Gopalan Ambalathil Meethal ceased to be Additional Director on 24 Jan 2025. Gopalan Ambalathil Meethal was appointed as Director on 25 Mar 2023. Zebx Pharmaceuticals has 6 board changes on record in total.
The registered office of Zebx Pharmaceuticals is at No.60 15th Main Road Rajmahal Vilas Extension Rmv Extn, Bangalore, Karnataka, India – 560080.
Zebx Pharmaceuticals operates in the education and learning industry, in the education segment.
Zebx Pharmaceuticals has open charges of ₹4 Cr and no satisfied charges on record as per latest MCA filings.
Zebx Pharmaceuticals can be reached at its registered office: No.60 15th Main Road Rajmahal Vilas Extension Rmv Extn, Bangalore, Karnataka, India – 560080.